The Prognosis of ART Is Not Altered in Cystic Fibrosis Women: A Case-Report Study.

assisted reproductive techniques cystic fibrosis female infertility pregnancy pregnancy outcome

Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2022
Historique:
received: 10 09 2021
accepted: 17 01 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 23 4 2022
Statut: epublish

Résumé

Unlike in men, a very limited number of studies were focused on the specificity of ART management of cystic fibrosis (CF) in women. The purpose of this study was to determine the causes of infertility in patients, the appropriate ART treatment, and their prognosis in terms of pregnancy. We conducted a multicentre analytical case-control study including CF women who were age-matched to non-CF women. We reported the causes of infertility, the ART management type and pregnancy outcomes. 17 cases were compared to 34 controls. There was no significant difference between the groups concerning cause infertility. There was a non-statistically significant trend with a lower antral follicle count in CF compared to controls (19.5 versus 26.8, p=0.08). IUI seemed to be as successful as IVF/ICSI in CF as opposed to controls where the IVF/ICSI was the most effective (in CF group for HCG >100 UI/L: 38.8% vs. 36.8%, p=0.4175). There were more embryos obtained in CF than in controls (3.1 versus 1.6, p=0.02). The number of oocytes and embryos obtained and pregnancy outcomes remained similar between DF508 homozygous group and others CFTR mutations group. The results of ART procedures and pregnancy evolution were not influenced by FEV1. In absence of any other pathology, IUI may be first option for CF women. If insemination fails, IVF with a low dose of gonadotropins may be more appropriate to prevent the risk of hyperstimulation syndrome. FEV1 and genetic do not seem to be contributing factors in the prognosis of ART.

Identifiants

pubmed: 35265034
doi: 10.3389/fendo.2022.773753
pmc: PMC8898889
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

773753

Informations de copyright

Copyright © 2022 Braham, Morisot, Boukaïdi, Perceval, Durieu, Rousset-Jablonski, Hieronimus, Leroy and Chevalier.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Paediatr Respir Rev. 2015 Oct;16 Suppl 1:25-7
pubmed: 26410278
Fertil Steril. 1973 Jul;24(7):512-6
pubmed: 4715225
Pediatr Pulmonol. 2014 Apr;49(4):309-17
pubmed: 24339235
Endocrinol Metab Clin North Am. 1998 Dec;27(4):851-76
pubmed: 9922911
Am J Dis Child. 1980 Dec;134(12):1139-42
pubmed: 7446500
Paediatr Respir Rev. 2010 Jun;11(2):80-3
pubmed: 20416542
Lancet. 2019 Nov 23;394(10212):1940-1948
pubmed: 31679946
Mol Cell Endocrinol. 2006 May 16;250(1-2):106-13
pubmed: 16414184
Endocrinology. 2008 Jun;149(6):2790-7
pubmed: 18325992
Am J Obstet Gynecol. 1970 Oct 15;108(4):673-4
pubmed: 5505999
Orphanet J Rare Dis. 2012 Mar 01;7:14
pubmed: 22380742
Acta Obstet Gynecol Scand. 2002 Aug;81(8):698-705
pubmed: 12174152
Lancet. 2016 Nov 19;388(10059):2519-2531
pubmed: 27140670
Morphologie. 2019 Mar;103(341):4-10
pubmed: 30528305
J Cyst Fibros. 2020 Jan;19(1):80-83
pubmed: 31272894
N Engl J Med. 2011 Nov 3;365(18):1663-72
pubmed: 22047557
Reprod Biomed Online. 2019 Sep;39(3):492-495
pubmed: 31256948
Am J Physiol. 1999 Sep;277(3):C563-71
pubmed: 10484343
Genes (Basel). 2020 May 26;11(6):
pubmed: 32466381
Am J Pathol. 1994 May;144(5):906-14
pubmed: 7513949
Nat Cell Biol. 2003 Oct;5(10):902-6
pubmed: 14515130
Fertil Steril. 2014 Nov;102(5):1324-30
pubmed: 25217870
J Clin Endocrinol Metab. 2012 Mar;97(3):923-32
pubmed: 22170719
Pediatrics. 1997 Jan;99(1):29-34
pubmed: 8989333
Hum Reprod. 2010 Jul;25(7):1744-54
pubmed: 20406739
Chest. 2000 Jul;118(1):85-91
pubmed: 10893364
J Cyst Fibros. 2015 May;14(3):398-402
pubmed: 25280785
J Androl. 1998 Mar-Apr;19(2):242-8
pubmed: 9570749
J Cyst Fibros. 2019 Jul;18(4):525-529
pubmed: 30366850
Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9816-21
pubmed: 17519339
J Clin Med. 2020 Aug 21;9(9):
pubmed: 32825766

Auteurs

Inès Braham (I)

Université Côte d'Azur, CHU de Nice, Département d'Endocrinologie-Diabétologie et Reproduction, Nice, France.

Adeline Morisot (A)

Université Côte d'Azur, CHU de Nice, Département de Santé Publique, Nice, France.

Samir Boukaïdi (S)

Université Côte d'Azur, CHU de Nice, Centre d'aide médicale à la procréation, Nice, France.

Marie Perceval (M)

Hospices Civils de Lyon, CHU de Lyon, Centre de Ressources et de Compétences de la Mucoviscidose, Lyon, France.

Isabelle Durieu (I)

Hospices Civils de Lyon, CHU de Lyon, Centre de Ressources et de Compétences de la Mucoviscidose, Lyon, France.

Christine Rousset-Jablonski (C)

Hospices Civils de Lyon, CHU de Lyon, Service de gynécologie-obstétrique, Lyon, France.

Sylvie Hieronimus (S)

Université Côte d'Azur, CHU de Nice, Département d'Endocrinologie-Diabétologie et Reproduction, Nice, France.

Sylvie Leroy (S)

Université Côte d'Azur, CHU de Nice, Centre de Ressources et de Compétences de la Mucoviscidose, Nice, France.

Nicolas Chevalier (N)

Université Côte d'Azur, CHU de Nice, Département d'Endocrinologie-Diabétologie et Reproduction, Nice, France.
Université Côte d'Azur, Inserm U1065, C3M, Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH